170521 ⎘
Assays involving biological materials from specific organisms or of a specific nature from animals; from humans Assays involving albumins other than in routine use for blocking surfaces or for anchoring haptens during immunisation
Sub-classes:PHARMACOKINETIC MODELING SYSTEMS FOR IMPROVED THERAPEUTIC DOSING
#2TEST PIECE FOR MEASURING ALBUMIN AND METHOD FOR MEASURING ALBUMIN
#3REAGENT, METHOD, AND DEVICE FOR DETECTING ALBUMIN
#4DIGITALIZED HUMAN ORGANOIDS AND METHODS OF USING SAME
#5METHODS FOR DETECTING HOOK EFFECT(S) ASSOCIATED WITH ANAYLTE(S) OF INTEREST DURING OR RESULTING FROM THE CONDUCTANCE OF DIAGNOSTIC ASSAY(S)
#6METHOD FOR EXAMINING BLOOD SAMPLE
#7DETECTION OF GLYCATED ALBUMIN IN DIABETES-AFFECTED BIOLOGICAL SAMPLES
#8Lateral Flow Device for Allograft Rejection
#9METHOD FOR PROVIDING INFORMATION RELATED TO TYPE OF CANCER, SYSTEM FOR PROVIDING INFORMATION RELATED TO TYPE OF CANCER
#10THERAPEUTIC USES OF DULAGLUTIDE
#11METHOD FOR MEASURING AGGREGATING PROTEINS, METHOD FOR VISUALIZING AGGREGATION, AND KIT USED THEREFOR
#12SAMPLE ANALYSIS METHOD, CAPILLARY ELECTROPHORESIS SOLUTION, AND SAMPLE ANALYSIS KIT
#13BIOMARKERS FOR COGNITIVE DYSFUNCTION DISEASES AND METHOD FOR DETECTING COGNITIVE DYSFUNCTION DISEASE USING BIOMARKERS
#14IN VITRO DIAGNOSTIC METHOD FOR ALZHEIMER'S DISEASE BASED ON THE ALBUMIN REDOX LEVEL IN THE CEREBROSPINAL FLUID
#15QUANTITATIVE BIOMARKERS FOR ASSESSING MILD TRAUMATIC BRAIN INJURY AND METHODS OF USE THEREOF
#16Preparation of nucleated RBC (NRBC) analogs for use as reference hematology controls in automated hematology analyzers
#17Methods for detecting hook effect(s) associated with anaylte(s) of interest during or resulting from the conductance of diagnostic assay(s)
#18Passive mixing microfluidic urinary albumin chip (UAL-chip) for chronic kidney disease
#19Urine sample testing apparatus and apparatus for processing measurement results of urine sample
#20DIGITALIZED HUMAN ORGANOIDS AND METHODS OF USING SAME
#21Test strip for detecting microalbumin in urine with high sensitivity
#22Means and methods for determining risk of type-1 diabetes by serum protein biomarkers
#23Plasmonic biosensor
#24Methods and Materials for Producing Hybrid Cell Lines
#25Biomarkers for Typing Allograft Recipients
#26BIOMARKERS FOR COGNITIVE DYSFUNCTION DISEASES AND METHOD FOR DETECTING COGNITIVE DYSFUNCTION DISEASE USING BIOMARKERS
#27VITRO DIAGNOSTIC METHOD FOR ALZHEIMER'S DISEASE BASED ON THE ALBUMIN REDOX LEVEL IN THE CEREBROSPINAL FLUID
#28Urine sample testing apparatus and apparatus for processing measurement result of urine sample
#29DETERMINATION METHOD AND SYSTEM THEREOF
#30BIOMARKERS FOR GASTRIC CANCER AND USES THEREOF
#31METHOD FOR DETERMINING ALZHEIMER'S DISEASE RISK
#32METHODS AND COMPOSITIONS FOR DETECTING ENDOMETRIAL OR OVARIAN CANCER
#33Blood volume analysis with volume-aware blood component measures and treatment
#34Device and method for detecting creatinine and albumin to creatinine ratio
#35METHOD FOR SCREENING DIABETIC NEPHROPATHY IN A SUBJECT
#36IN VITRO DIAGNOSTIC METHOD FOR ALZHEIMER'S DISEASE BASED ON THE ALBUMIN REDOX LEVEL IN THE CEREBROSPINAL FLUID
#37Electrochemical biosensor and a method of sensing albumin and its complexes
#38Methods for assessing biospecimen integrity
#39Urine sample testing apparatus and apparatus for processing measurement result of urine sample
#40Means and methods for determining risk of type-1 diabetes by serum protein biomarkers
#41Method for detecting albumin based on colorimetric assay and system thereof
#42Chemical and biochemical adducts as biomarkers for organophosphate exposure
#43Method for detecting analyte, detection reagent kit, and detection reagent
#44Methods for assessing biospecimen integrity
#45Biomarkers for gastric cancer and uses thereof
#46SYSTEMS AND METHODS FOR MULTI-ANALYSIS
#47Methods and devices for detection and measurement of analytes
#48Method of determining temperature and method of detecting a target peptide
#49TEST PAPER FOR DETECTION OF DIABETIC NEPHROPATHY
#50BIOMARKERS FOR COGNITIVE DYSFUNCTION DISEASES AND METHOD FOR DETECTING COGNITIVE DYSFUNCTION DISEASE USING BIOMARKERS
#51TRANSTHYRETIN AMYLOID-SELECTIVE AND POLYREACTIVE CATABODIES
#52Method for the detection of the prozone effect of photometric assays
#53Method and biomarkers for the detection of dengue hemorrhagic fever
#54Flavonoid compounds of low toxicity for biological imaging applications
#55Method for the detection of an albumin isoform
#56Methods and compositions for detecting endometrial or ovarian cancer
#57Methods and devices for detection and measurement of analytes
#58Aptamers for detection and measurement of analytes
#59Process for detection of alzheimer's disease from a serum sample
#60Detection and measurement of blood-feeding activity
#61In vitro method for analyzing a comparison of an indicative numberic value to a predetermined threshold so as to assess a likelihood of risk or presence of organ failure
#62Automated blood analyzer
#63AUTOMATED BLOOD ANALYZER
#64Automated total body albumin analyzer
#65Methods and biomarkers for the detection of dengue hemorrhagic fever
#66Methods and compositions for detecting endometrial or ovarian cancer
#67Detector and detection method
#68Urine sample testing apparatus and apparatus for processing measurement result of urine sample
#69BIOMARKERS AND ASSAYS FOR DIABETES
#70Chemical and biochemical adducts as biomarkers for organophosphate exposure
#71Albumin-bound protein/peptide complex as a biomarker for disease
#72Assay for evaluating affinity and specificity of ligand-albumin binding
#73CLASSIFYING AMYLOIDOSIS
#74Modulation of the Neuroendocrine System as a Therapy for Motor Neuron Disease
#75Method for diagnosing the metabolic syndrome (MS)
#76Detection and measurement of blood-feeding activity
#77Method for diagnosing tumors
#78RAPID TEST FOR GLYCATED ALBUMIN IN SALIVA
#79DETECTION OF PHYSIOLOGICALLY ACCEPTABLE POLYMER MOLECULES USING NEAR INFRARED SPECTROSCOPY
#80Detection and measurement of blood-feeding activity
#81Methods for determining active ingredients in pro-drug PEG protein conjugates with releasable PEG reagents (in vitro de-pegylation)
#82Monoclonal and polyclonal antibodies to equine albumin and hemoglobin and apparatus and methods using the antibodies in the identification and localization of ulcers and other digestive tract bleeding in equines
#83Urinary proteomic biomarker patterns in preeclampsia
#84METHOD FOR MEASURING PROTEIN
#85Rapid test for glycated albumin in blood
#86D/P CREATININE MARKER, METHOD OF DETERMINING D/P CREATININE, AND INTENDED USE THEREOF
#87Method for assaying glycated albumin
#88Targets for Detection of Ischemia
#89Method for diagnosing tumors
#90Use of C3a and derivatives thereof as a biomarker for colorectal adenoma and/or carcinoma; method for detection and test system
#91Use of transthyretin as a biomarker for colorectal adenoma and/or carcinoma; method for detection and test system
#92Test kit for the rapid detection and localization of digestive tract bleeding in equines
#93Albumin binding sites for evaluating drug interactions and methods of evaluating or designing drugs based on their albumin binding properties
#94Rapid test for glycated albumin in blood
#95Modulation of the neuroendoctrine system as a therapy for motor neuron disease
#96Method of measuring binding site on plasma protein of plasma protein-binding drug and method of measuring plasma protein mutation
#97Method and system for optically performing an assay to determine a medical condition